Company
MELINTA THERAPEUTICS, INC. /NEW/ (0001461993)
Standardized SEC financial data for MELINTA THERAPEUTICS, INC. /NEW/ — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001461993 · Pharmaceutical Preparations.
Gross margin
100.0%
Operating margin
-467.9%
Net margin
-464.2%
Return on equity
-82.7%
ROIC
-101.3%
Free cash flow
-$173.2M
Debt / equity
0.08×
Current ratio
1.12×
Ratios for fiscal year 2017, standardized from SEC filings.
Income statement
| USD | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Revenue | $18.0M | $33.9M | — |
| Cost of revenue | $0 | $0 | $41.1M |
| Gross profit | $18.0M | $33.9M |
Balance sheet
| USD | FY2016 | FY2017 | FY2018 | FY2018 |
|---|---|---|---|---|
| Cash & equivalents | $11.4M | $128.6M | — | $82.0M |
| Accounts receivable | $6.2M | — | — | — |
Cash flow
| USD | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Operating cash flow | -$70.6M | -$75.6M | -$171.5M |
| Capital expenditures | $463K | $849K | $1.7M |
| Free cash flow | -$71.0M | -$76.4M |
Get 0001461993 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001461993/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001461993/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"